Resultados de búsqueda - Macia-Rivas, L

  • Mostrando 1 - 4 Resultados de 4
Limitar resultados
Exportar CSV
  1. 1

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Artículo | por Jimenez-Fonseca, P; Foy, V; Raby, S; Carmona-Bayonas, A; Macia-Rivas, L; Arrazubi, V; Lavin, DC; Gil, RHS; Custodio, A; Cano, JM; Montes, AF; Mirallas, O; Declara, IM; Tocino, RV; Visa, L; Limon, ML; Pimentel, P; Lago, NM; Sauri, T; Richard, MM; Mangas, M; Raga, MG; Calvo, A; Reguera, P; Granja, M; Carnicero, AM; Perez, CH; Cerda, P; Gonzalez, LG; Navalon, FG; Barcia, VP; Abad, D; Martin, MR; Weaver, J; Mansoor, W; Gallego, J | Publicado 2023 |
  2. 2

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Artículo | por Jimenez-Fonseca, P; Foy, V; Raby, S; Carmona-Bayonas, A; Macia-Rivas, L; Arrazubi, V; Lavin, DC; Gil, RHS; Custodio, A; Cano, JM; Montes, AF; Mirallas, O; Declara, IM; Tocino, RV; Visa, L; Limon, ML; Pimentel, P; Lago, NM; Sauri, T; Richard, MM; Mangas, M; Raga, MG; Calvo, A; Reguera, P; Granja, M; Carnicero, AM; Perez, CH; Cerda, P; Gonzalez, LG; Navalon, FG; Barcia, VP; Abad, D; Martin, MR; Weaver, J; Mansoor, W; Gallego, J | Publicado 2023 |
  3. 3

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Artículo | por Jimenez-Fonseca, P; Foy, V; Raby, S; Carmona-Bayonas, A; Macia-Rivas, L; Arrazubi, V; Lavin, DC; Gil, RHS; Custodio, A; Cano, JM; Montes, AF; Mirallas, O; Declara, IM; Tocino, RV; Visa, L; Limon, ML; Pimentel, P; Lago, NM; Sauri, T; Richard, MM; Mangas, M; Raga, MG; Calvo, A; Reguera, P; Granja, M; Carnicero, AM; Perez, CH; Cerda, P; Gonzalez, LG; Navalon, FG; Barcia, VP; Abad, D; Martin, MR; Weaver, J; Mansoor, W; Gallego, J | Publicado 2023 |
  4. 4

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Artículo | por Jimenez-Fonseca P.; Foy V.; Raby S.; Carmona-Bayonas A.; Macía-Rivas L.; Arrazubi V.; Cacho Lavin D.; Hernandez San Gil R.; Custodio A.; Cano J.M.; Fernández Montes A.; Mirallas O.; Macias Declara I.; Vidal Tocino R.; Visa L.; Limón M.L.; Pimentel P.; Martínez Lago N.; Sauri T.; Martín Richard M.; Mangas M.; Gil Raga M.; Calvo A.; Reguera P.; Granja M.; Martín Carnicero A.; Hernández Pérez C.; Cerdá P.; Gomez Gonzalez L.; Garcia Navalon F.; Pacheco Barcia V.; Gutierrez Abad D.; Ruiz Martín M.; Weaver J.; Mansoor W.; Gallego J. | Publicado 2023 |

Herramientas de búsqueda: